Mark Sabag
Role in collected records: See "Remarks". Collected issuer coverage: TEVA. Form 4 rows and their summary range show transaction dates from collected records. The separate Form 144 table shows filing dates. Open the linked filings for their full terms and submission details. Filed as Sabag Mark.
Collected Form 4 transaction rows
Reported purchases, sales, grants, exercises and other changes. One filing can contain multiple transaction rows.
| Company | Action | Value |
|---|---|---|
| TEVATeva Pharmaceutical Industries Ltd2026-11-05 | Option exercise | $1.6M |
| TEVATeva Pharmaceutical Industries Ltd2026-11-05 | Sale | $1.9M |
| TEVATeva Pharmaceutical Industries Ltd2026-11-05 | Option exercisederivative | — |
Sales they filed notice of
Form 144 gives notice of a proposed sale under Rule 144. It is not SEC approval or proof of a completed sale; these notices are kept separate from the transaction rows above.
| Company | Shares | Value |
|---|---|---|
| TEVA | 46K | $1.9M |
Source: collected SEC Form 4 records and Form 144 notices via EDGAR. This site matches Form 144 seller names exactly to the collected Form 4 filed name; a name match alone does not establish identity. Form 4 transaction value uses reported shares and price and is blank for zero or missing prices. That does not establish an award’s economic value. Records may be incomplete; a sale alone does not establish motive. SEC guide to insider reports.
Follow Mark Sabag by email
Mark Sabag's new Form 4 trades, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.